Protein Functionalization: Giving proteins the 'superpowers' they naturally don't have

In today's fast-paced development of synthetic biology, biomedicine, and high-end food manufacturing, proteins have long leaped beyond their traditional role as 'basic nutrients' and become core functional carriers across multiple fields. From targeted protein drugs and highly efficient industrial enzymes to highly adaptable functional food ingredients, protein functionalization technology is becoming a key bridge connecting basic biomolecular research with industrial applications, completely changing the way humans use proteins. However, the structure and function of natural proteins are limited by evolutionary history and often struggle to meet the stringent demands of industrial production. Protein functionalization technology was born to solve this very problem.

I. So, what is protein functionalization?

Protein functionalization

 Protein functionalization

Protein functionalization refers to the process of giving proteins new functions or enhancing their original performance through chemical or biological targeted modifications and alterations.

If natural proteins are like 'factory-made tools,' protein functionalization is like precision 'secondary processing' of these tools—adding handles, rust-resistant coatings, or customized blades, so they perform far beyond their original design in specific applications. This transformation can focus on four core attributes:

Stability functionalization — making proteins 'tough.' Natural enzymes often lose activity within minutes under high temperatures, extreme pH, or in organic solvents. By introducing disulfide bonds and optimizing hydrophobic core packing, their working window can be extended from 'a few hours' to 'weeks' or even 'months.' In the detergent and biofuel industries, stability functionalization is the first hurdle for industrial enzymes to reach commercialization.

Targeted functionalization — equipping proteins with a 'navigation system.' In antibody drugs, enhancing binding precision through affinity maturation, followed by site-specific conjugation of cytotoxic payloads (i.e., antibody-drug conjugates, ADCs), enables antibodies to accurately lock onto diseased cells and efficiently kill them—addressing the two critical steps of 'finding' and 'hitting hard.' Recombinant protein drugs optimized through site-specific functionalization can have significantly extended circulation half-lives and greatly improved target selectivity.

Catalytic functionalization — turning 'silent' scaffolds into active centers. This is one of the most challenging levels of protein functionalization: it includes expanding substrate scope and modifying selectivity in existing enzymes (like introducing transglycosylation preference in glycoside hydrolases), as well as embedding catalytic residue sets into non-catalytic protein scaffolds through computational design to perform entirely new chemical reactions. The latter is known as 'de novo enzyme design'—for example, Baker's team designed Kemp elimination enzymes (KE series) and Retro-Aldolase (RA series), representing the cutting edge of catalytic functionalization.

Responsive functionalization — making proteins 'sense' their environment. By introducing conformational switches sensitive to pH, temperature, light, or specific small molecules, you can create 'smart proteins' that activate only under predetermined conditions—like protein nanocarriers that release drugs only in the acidic conditions of a tumor microenvironment.

II. Why is protein functionalization so important?

As the technology continues to mature, protein functionalization has expanded from laboratory research scenarios to fully penetrate core industries such as biomedicine, industrial biomanufacturing, high-end food, and biomaterials, becoming a key driving force for the high-quality development of the biotech industry. The strategic value of protein functionalization can be understood from three dimensions.

1. Biomedicine: Supporting the upgrade of precision medicine

In the fields of antibody drugs, recombinant protein drugs, vaccine development, and targeted delivery, protein functionalization is the core key to enhancing drug druggability. Through precise functional modification, core issues such as short half-life, weak targeting, high immunogenicity, and poor stability of medicinal proteins can be effectively addressed. Recombinant protein drugs optimized for targeted functionalization can significantly improve their circulating half-life and targeted binding accuracy in vivo, effectively reducing drug side effects and enhancing treatment efficacy.

At the same time, protein functionalization technology supports the development of innovative products such as exosome vaccines, nanobioprobes, and targeted vectors, providing core technical support for cutting-edge fields like tumor treatment, immune regulation, and gene therapy.

2. Industrial Biomanufacturing: Cost reduction and efficiency improvement, supporting green production

Industrial enzymes are the core catalysts in biomanufacturing, while natural enzymes have poor environmental tolerance, low catalytic efficiency, and poor reusability, which are the main bottlenecks restricting green industrial production. By optimizing the spatial structure of enzymes through protein functionalization technology, thermal stability, acid and base tolerance, and substrate specificity can be significantly enhanced, making enzyme preparations suitable for complex production scenarios such as high-temperature fermentation and extreme industrial systems. Industrial enzymes that have been functionally modified have significantly improved catalytic efficiency and reuse rates, effectively reducing energy consumption and consumable costs in industrial production, replacing traditional high-pollution chemical processes, and supporting the green transformation of the biomanufacturing industry.

3. High-end food and biomaterials sector: expanding new application boundaries

Currently, food consumption demand has shifted from "satiety" to "nutrition and function," making functional food proteins a hot topic in the industry. Through protein functionalization technology, the physicochemical properties of milk protein and plant protein can be optimized, reducing protein sensitization, improving digestion and absorption rates, while simultaneously endowing proteins with physiological functions such as antioxidant, immunomodulatory, and gut regulation. In addition, functionalized proteins can serve as core raw materials to build new biomaterials such as biohydrogels, tissue engineering scaffolds, biosensor coatings, and nano delivery carriers. Through functional modification, they optimize adhesion, biocompatibility, and responsiveness, expanding the boundaries of high-end industrial applications such as medical restoration, precision delivery, and biological testing.

III. Four technical paths, a common bottleneck

Four technical approaches

The industry has developed multiple mature technical routes.

Chemical modification is the most classic approach, including PEGylation (to extend half-life), biotinylation (for affinity capture), fluorescent labeling (for detection and tracking), and site-specific conjugation based on click chemistry. Its advantage lies in its relative ease of operation, while the challenge is how to achieve site selectivity among numerous reactive residues—precisely introducing the modification group at a specific position without affecting the protein's key functional regions.

Enzymatic modification uses tool enzymes like sortase or glycosidases to catalyze the formation of specific chemical bonds, achieving site-specific protein modification. This method offers high regional selectivity and biocompatibility, but it places higher demands on the performance of the tool enzymes themselves—their activity, stability, and substrate tolerance.

Genetic fusion involves fusing the target protein with a functional protein (such as self-assembling proteins, fluorescent proteins, affinity tags, etc.) at the gene level, achieving functionalized proteins in one step. This fundamentally solves the site-selectivity problem of chemical modification but poses challenges to protein folding and expression systems.

Incorporation of non-natural amino acids is a cutting-edge technology that has emerged in recent years—by introducing non-natural amino acids with reactive functional groups at specific sites in the protein, it provides a unique "chemical handle" for subsequent precise conjugation, avoiding cross-reaction with natural amino acid side chains.

No matter which technical route is used, protein functionalization faces a common underlying bottleneck: the "design–validate–iterate" loop is too long and too expensive. The sequence space is enormous (for a protein with 300 amino acids, the possible sequence combinations are 20 to the power of 300), and traditional R&D relies on expert experience and repeated trial-and-error in wet experiments, with a single cycle lasting several months. Additionally, a large amount of experimental data is fragmentarily distributed and cannot systematically feed back into the design. This is exactly where AI and automation technology bring their core value.

IV. A New Paradigm for AI-Driven Protein Functionalization

In response to the efficiency bottlenecks of traditional R&D, an intelligent, full-chain R&D model is emerging. MatwingsVenus™ (Xiaowu™), a conversational protein R&D agent under Shanghai Matwings Technology, represents a practical example of this direction.

In April 2026, Matwings Technology officially launched this platform. Centered around the agent, it supports retrieval of protein data with real labels at a scale of tens of billions, integrates over 200 protein design tools, more than 50 platform-certified experts, and over 30 skill sets fine-tuned by specialists across various fields. Users only need to input functional requirements in natural language, and the system will automatically break down tasks, coordinate capabilities like structure prediction, functional site analysis, and mutation design and screening, completing the entire computational workflow from in-depth research to sequence design.

At the core of the platform is Matwings Technology’s self-developed AIACCLBIO® protein large model, along with the world’s largest protein sequence dataset constructed by its team, VenusPod, which contains nearly 9 billion protein sequences and hundreds of millions of functional labels. These data infrastructures enable AI to accurately predict key protein parameters such as thermal stability, catalytic activity, and target specificity.

Even more groundbreaking is its "dry-wet closed-loop" approach: after the agent completes the design, the platform can automatically import candidate sequences into the experimental workflow, driving robots to perform sample preparation, protein purification, and functional testing. The experimental results are then fed back into the next round of AI design—creating a closed-loop iteration of "computation-driven wet experiments and wet experiments feeding back into computation."

This model has already been validated in real projects. For a de novo design project targeting an immune regulatory receptor, the platform automatically completed scaffold screening, interface design, and sequence optimization, successfully generating dozens of new binding molecules with in vitro cell-blocking activity, completing the full closed-loop of de novo molecule design. In the modification of the sweet protein Monellin, multi-round iterations of "AI design—automated experiments—AI feedback—redesign" produced candidate variants with sweetness tens of times higher than the wild type and heat resistance maintained at around 75°C.

From chemical modifications to gene fusions, from enzymatic catalysis to incorporation of non-natural amino acids—no matter the technical route, the shared value of the AI automation platform lies in transforming protein functional R&D from a "handcrafted workshop" reliant on personal experience into a "standardized, engineering-capable" process.

V. Outlook: The next stop for protein functionalization

Protein functionalization is moving from 'trial-and-error based on experience' to 'data-driven precise design.' From traditional manual modifications to AI-powered reconstruction, technological iterations have continuously expanded the application potential of proteins. According to market research firm Spherical Insights, the global functional protein market is estimated at around $8.1 billion in 2024 and is expected to grow to about $15.87 billion by 2035, with a compound annual growth rate of approximately 6.27%. Behind this growth is strong and ongoing demand for customized protein functions across biopharmaceuticals, industrial catalysis, food technology, and biomaterials.

Platforms like MatwingsVenus™ (Xiaowu™) are making 'giving new functions to proteins' something that was once specialized knowledge for a few experts into infrastructure that R&D teams across various industries can directly use. When AI can understand natural language instructions like 'I need an enzyme with improved alkalinity tolerance' and automatically handle the entire process from sequence design to experimental validation, the barrier to protein functionalization will be fundamentally lowered.

In the future, as intelligent R&D technologies continue to spread, customized functional proteins will infiltrate more industrial scenarios, opening a new chapter in bio-manufacturing.